GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Enzychem Lifesciences Corp (XKRX:183490) » Definitions » Net Margin %

Enzychem Lifesciences (XKRX:183490) Net Margin % : -4.89% (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Enzychem Lifesciences Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Enzychem Lifesciences's Net Income for the three months ended in Mar. 2024 was ₩-1,089 Mil. Enzychem Lifesciences's Revenue for the three months ended in Mar. 2024 was ₩22,244 Mil. Therefore, Enzychem Lifesciences's net margin for the quarter that ended in Mar. 2024 was -4.89%.

The historical rank and industry rank for Enzychem Lifesciences's Net Margin % or its related term are showing as below:

XKRX:183490' s Net Margin % Range Over the Past 10 Years
Min: -130.93   Med: -60.73   Max: -9.69
Current: -9.69


XKRX:183490's Net Margin % is ranked worse than
68.53% of 1020 companies
in the Drug Manufacturers industry
Industry Median: 3.225 vs XKRX:183490: -9.69

Enzychem Lifesciences Net Margin % Historical Data

The historical data trend for Enzychem Lifesciences's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzychem Lifesciences Net Margin % Chart

Enzychem Lifesciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -53.64 -67.81 -121.28 -94.20 -12.27

Enzychem Lifesciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15.38 -14.08 -13.33 -7.89 -4.89

Competitive Comparison of Enzychem Lifesciences's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Enzychem Lifesciences's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enzychem Lifesciences's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Enzychem Lifesciences's Net Margin % distribution charts can be found below:

* The bar in red indicates where Enzychem Lifesciences's Net Margin % falls into.



Enzychem Lifesciences Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Enzychem Lifesciences's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-9326.412/76038.894
=-12.27 %

Enzychem Lifesciences's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin=Net Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-1088.694/22244.352
=-4.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Enzychem Lifesciences  (XKRX:183490) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Enzychem Lifesciences Net Margin % Related Terms

Thank you for viewing the detailed overview of Enzychem Lifesciences's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Enzychem Lifesciences (XKRX:183490) Business Description

Traded in Other Exchanges
N/A
Address
27 Gangnamdae-ro Seocho-gu, 10th Floor, aT Center, Seoul, KOR, 135-280
Enzychem Lifesciences Corp develops and produces APIs and functional health foods. It manufactures veterinary medicine tablets, capsules, syrups, injections, ointments, solutions for the diagnosis and prevention of various diseases. The company is also developing drugs to treat chemotherapy-induced neutropenia, chemo-radiation therapy-induced oral mucositis, asthma, psoriasis, rheumatoid arthritis, and others.

Enzychem Lifesciences (XKRX:183490) Headlines

No Headlines